These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9563495)

  • 1. Inhibiting Ras prenylation increases the radiosensitivity of human tumor cell lines with activating mutations of ras oncogenes.
    Bernhard EJ; McKenna WG; Hamilton AD; Sebti SM; Qian Y; Wu JM; Muschel RJ
    Cancer Res; 1998 Apr; 58(8):1754-61. PubMed ID: 9563495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
    Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell lines.
    Lerner EC; Zhang TT; Knowles DB; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1997 Sep; 15(11):1283-8. PubMed ID: 9315095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras.
    Brunner TB; Cengel KA; Hahn SM; Wu J; Fraker DL; McKenna WG; Bernhard EJ
    Cancer Res; 2005 Sep; 65(18):8433-41. PubMed ID: 16166322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts.
    Sun J; Qian Y; Hamilton AD; Sebti SM
    Oncogene; 1998 Mar; 16(11):1467-73. PubMed ID: 9525745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines.
    Bernhard EJ; Stanbridge EJ; Gupta S; Gupta AK; Soto D; Bakanauskas VJ; Cerniglia GJ; Muschel RJ; McKenna WG
    Cancer Res; 2000 Dec; 60(23):6597-600. PubMed ID: 11118040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farnesyltransferase inhibitor effects on prostate tumor micro-environment and radiation survival.
    Shi Y; Wu J; Mick R; Cerniglia GJ; Cohen-Jonathan E; Rhim JS; Koch CJ; Bernhard EJ
    Prostate; 2005 Jan; 62(1):69-82. PubMed ID: 15389805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
    Feldkamp MM; Lau N; Guha A
    Oncogene; 1999 Dec; 18(52):7514-26. PubMed ID: 10602510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of p21Ras-mediated apoptosis induced by protein kinase C inhibition and application to human tumor cell lines.
    Liou JS; Chen JS; Faller DV
    J Cell Physiol; 2004 Feb; 198(2):277-94. PubMed ID: 14603530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts.
    Bernhard EJ; Kao G; Cox AD; Sebti SM; Hamilton AD; Muschel RJ; McKenna WG
    Cancer Res; 1996 Apr; 56(8):1727-30. PubMed ID: 8620483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model.
    Cengel KA; McKenna WG
    Crit Rev Oncol Hematol; 2005 Aug; 55(2):103-16. PubMed ID: 16006139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells.
    Morgan MA; Sebil T; Aydilek E; Peest D; Ganser A; Reuter CW
    Br J Haematol; 2005 Sep; 130(6):912-25. PubMed ID: 16156861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS.
    Toulany M; Dittmann K; Baumann M; Rodemann HP
    Radiother Oncol; 2005 Feb; 74(2):117-29. PubMed ID: 15734199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras.
    Cohen-Jonathan E; Evans SM; Koch CJ; Muschel RJ; McKenna WG; Wu J; Bernhard EJ
    Cancer Res; 2001 Mar; 61(5):2289-93. PubMed ID: 11280800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of the v-myc oncogene with H-ras on radioresistance.
    McKenna WG; Weiss MC; Endlich B; Ling CC; Bakanauskas VJ; Kelsten ML; Muschel RJ
    Cancer Res; 1990 Jan; 50(1):97-102. PubMed ID: 2403420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells.
    Chi S; Kitanaka C; Noguchi K; Mochizuki T; Nagashima Y; Shirouzu M; Fujita H; Yoshida M; Chen W; Asai A; Himeno M; Yokoyama S; Kuchino Y
    Oncogene; 1999 Apr; 18(13):2281-90. PubMed ID: 10327074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo.
    Gupta AK; Cerniglia GJ; Mick R; McKenna WG; Muschel RJ
    Cancer Res; 2005 Sep; 65(18):8256-65. PubMed ID: 16166302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
    Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
    Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.